Benign Palpitations: Symptoms, Causes & Treatment

Palpitations — the conscious, unpleasant awareness of one's heartbeat — is one of the most common cardiac symptoms prompting medical consultation (accounting for 16% of primary care presentations). Patients describe sensations as fluttering, pounding, racing, skipping, stopping, or thudding. While palpitations are distressing, the vast majority — particularly in patients without structural heart disease — are benign and self-limiting.

Benign palpitations fall into three principal categories: (1) Physiological palpitations: enhanced awareness of normal sinus rhythm during tachycardia from caffeine, alcohol, nicotine, dehydration, fever, exercise, thyroid excess, anemia, or pregnancy; (2) Psychogenic palpitations: anxiety, panic disorder, and somatoform disorders — represent 35–45% of all palpitation presentations; (3) Benign ectopic beats: premature ventricular contractions (PVCs) — the most common arrhythmic cause — felt as a 'strong beat', 'skipped beat', or 'thud' from the compensatory pause; and premature atrial contractions (PACs). PVCs occur in >75% of adults on 24-hour Holter monitoring and are overwhelmingly benign in structurally normal hearts.

The critical clinical task is distinguishing benign palpitations from clinically significant arrhythmias: atrial fibrillation (irregular, sustained), supraventricular tachycardia (SVT — regular, rapid, sudden onset and offset), and ventricular tachycardia (in structural heart disease — associated with presyncope or syncope). Red flag features — syncope or presyncope, exercise-induced palpitations, family history of sudden cardiac death, and known structural heart disease — mandate urgent cardiac evaluation.

• Awareness of heartbeat: described as fluttering, pounding, thumping, stopping, or 'heart jumping out of chest'
• PVC sensations: characteristic 'dropped beat' followed by 'strong thump' — the compensatory pause then powerful post-pause beat
• Sudden-onset and sudden-offset rapid palpitations: suggest SVT (paroxysmal supraventricular tachycardia) — more concerning
• Associated mild lightheadedness, shortness of breath, or chest discomfort (often anxiety-related)
• More noticeable at rest or before sleep — when ambient noise is quiet and cardiac awareness increases
• Self-limiting in seconds to minutes in most cases

• Stimulants: caffeine (dose-dependent — >400 mg/day), alcohol (even small amounts in sensitive individuals), nicotine, energy drinks, pseudoephedrine, cocaine/amphetamines
• Anxiety disorders and panic attacks (35–45%): hyperventilation reduces CO2 — causes tachycardia and palpitations; heightened cardiac awareness is characteristic
• Benign ectopic beats: PVCs (most common arrhythmic cause — benign in structurally normal hearts; burden <10% is generally not harmful); PACs; often worse at rest
• Physiological states: pregnancy (increased cardiac output), exercise (sinus tachycardia), fever, dehydration, anemia
• Thyroid disorders: hyperthyroidism causes sustained sinus tachycardia and increased cardiac awareness
• Medications: beta-2 agonists (salbutamol), decongestants (pseudoephedrine), digoxin toxicity, TCAs, stimulant ADHD medications
• Fatigue and sleep deprivation: increase ectopic beat frequency

Detailed history: onset (sudden vs. gradual), regularity, duration, associated symptoms, triggers, red flags. 12-lead ECG: mandatory first investigation — may capture arrhythmia, delta waves (WPW), prolonged QT, or LBBB; normal ECG highly reassuring. Blood tests: TSH, CBC, electrolytes (K+, Mg2+ — hypokalemia/hypomagnesemia cause PVCs), glucose. Holter monitor (24–48 hours): correlate arrhythmia with symptoms during monitoring period — most useful if palpitations occur daily. Event monitor or implantable loop recorder (ILR): for infrequent (monthly) palpitations. Echocardiogram: if structural heart disease suspected (murmur, LVH, prior MI). Exercise stress test: if symptoms are exercise-related — excludes exercise-induced arrhythmia.

Lifestyle modification (most important): reduce or eliminate caffeine, alcohol, nicotine; ensure adequate sleep (7–8 hours); stress management; regular aerobic exercise (paradoxically reduces PVC burden in many). Reassurance and education: explaining the benign nature of PVCs and anxiety-related palpitations significantly reduces distress and healthcare-seeking — this alone resolves many cases. Beta-blockers (metoprolol or atenolol): effective for symptom reduction in bothersome PVCs and anxiety-related palpitations; first-line pharmacological therapy. Non-DHP calcium channel blockers (verapamil, diltiazem): alternative for PVC suppression. Anxiety treatment: cognitive behavioral therapy (CBT), low-dose beta-blockers for panic-associated palpitations, SSRI for anxiety disorder. Magnesium supplementation: may reduce PVC frequency in hypomagnesaemia. Ablation: catheter ablation for very frequent (>20%) symptomatic PVCs causing LV dysfunction.

• Benign palpitations themselves have no cardiac complications
• Missed serious arrhythmia (AF, VT) if red flags are not systematically evaluated
• Anxiety and health anxiety leading to repeated ED visits, over-investigation, and avoidance behavior
• Very frequent PVC burden (>20% of beats) can rarely cause PVC-induced cardiomyopathy requiring ablation

• Reduce stimulant intake: caffeine <200 mg/day, avoid energy drinks, quit smoking
• Adequate sleep and stress management — fatigue and anxiety are the most modifiable PVC triggers
• Treat underlying thyroid disease, anemia, and electrolyte abnormalities
• Regular moderate exercise: paradoxically decreases PVC burden in structurally normal hearts